Professional Documents
Culture Documents
Introduction To Pharmacology & Pharmacologic Principles
Introduction To Pharmacology & Pharmacologic Principles
Pharmacology
• the study of science of drugs
Drug
• any chemical that affects the processes of a living organism
I. Drug sources:
a. plants
b. animals
c. minerals
d. chemical synthesis/ biogenetic engineering
V. Drug references:
• American Hospital Formulary Service (AHFS) Drug Information
• Physicians’ Desk Reference (PDR)
• Package inserts
• Drug Facts and Comparisons
• Saunders/ Lipincott’s Nursing Drug Guide
• Journals
• Internet
VI. Phases of Drug Development
1. Preclinical trial
2. Phase 1
3. Phase 2
4. Phase 3
5. Phase 4
B. Controlled Substances:
controlled substances
OTC drugs
prescription drugs
orphan drugs
dependence
Schedule I Drugs
• high potential for abuse
• used for research only
• ex. heroin, marijuana, lysergic acid diethylamide (LSD)
Schedule II Drugs
• high abuse potential
• severe physical & psychologic dependence
• acceptable medical use, with restrictions
• ex. amphetamines, cocaine, mepiridine (Demerol) , morphine, anabolic steroids
Schedule IV
• low potential for abuse
• limited physical & psychological dependence
• ex. diazepam (Valium), phenobarbital, chlordiazepoxide (Librium)
Schedule V
• low potential for abuse
• acceptable medical use
• OTC narcotic drugs, sold only by registered pharmacists: buyer must be 18yo
• Ex. cough syrups with codeine eg. Guaifenesin,
diphenoxylate HCL with atropine ( Lomotil)
Pharmacologic Principles
I. Drug Action:
Pharmaceutics
Pharmacokinetics
Pharmacodynamics
Pharmaceutics
• the study of how various drug forms influence pharmacokinetic and pharmacodynamic
activities.
o disintegration
o dissolution
Pharmacokinetics
• the study of what the body does to the drug:
o Absorption
o Distribution
o Metabolism or biotransformation
o Excretion or elimination
Pharmacodynamics
• the study of what the drug does to the body :
o the mechanism of drug action in living tissues.
Pharmacotherapeutics
• the use of drugs and the clinical indications for drugs to prevent and treat diseases.
Pharmacognosy
• the study of natural ( plant and animal ) drug sources.
A. Pharmaceutic Phase
1. disintegration
2. dissolution
Rate limiting – time it takes for drug to disintegrate & dissolve to be absorbed by the body
B. Pharmacokinetic Phase
1. Absorption:
• passage of a drug into the bloodstream from site of administration
The rate at which the drug leaves its site of administration, and the extent to
which absorption occurs.
Bioavailability
Routes :
• a drug’s route of administration affects the rate and extent of absorption of the
drug.
o Enteral
o Parenteral
o Topical
Enteral Route
• drug is absorbed into the systemic circulation through
the oral or gastric mucosa, the small intestine, or rectum.
o oral
o sublingual*
o buccal
o rectal
Parenteral Route
• Intravenous *
• Intramuscular
• Subcutaneous
• Intradermal
• Intrathecal
• Intraarticular
Topical Route
• skin ( including transdermal patches )
• eyes, ears & nose
• lungs ( inhalation )*
• vagina
First – Pass Effect
• the metabolism of a drug and its passage from the liver into the circulation.
A drug given via the oral route may be extensively metabolized by the liver before
reaching the systemic circulation ( high first – pass effect ).
The same drug – given IV – bypasses the liver, preventing the first – pass effect
from taking place, the more drug reaches the circulation.
2. Distribution
• transport of a drug by the bloodstream to its site of action
3. Metabolism or biotransformation
• the transformation of a drug into an inactive metabolite, a more soluble compound or a
more potent metabolite
liver*
others: kidneys, lungs, plasma ,intestinal mucosa
Half-life
o time it takes for one half of the original amount of a drug in the body to be
removed.
o a measure the rate at which drugs are removed from the body
4. Excretion
• elimination of drugs from the body
kidneys*
others: lungs, exocrine glands (sweat, salivary or mammary glands),
skin & intestinal tract
C. Pharmacodynamics Phase
Onset of Action
• time it takes for the drug to elicit a therapeutic response
minimum effective concentration (MEC)
Peak Action
• time it takes for drug to reach its maximum therapeutic response
Duration of Action
• the time a drug concentration is sufficient to produce its therapeutic response
Receptor Theory
• most receptors are found on cell membrane
• drug binding occurs on receptors
• lock & key interaction
:
Agonist & antagonist:
Agonists
• drugs that attracts to receptors stimulate/ enhance a response
• ex. Insulin, isoproterenol – stimulate beta 1 receptor
Antagonists
• drugs that attracts to receptors block a response
• ex. cimetidine – blocks H2 receptor
Nonselective Drugs
• affect various receptors
• ex. Epinephrine acts on alpha1, beta 1 & 2 receptors
TI= LD50
ED50
Trough level
• lowest plasma concentration
• indicate rate of elimination
Loading dose
• large initial dose given for immediate response.
• given to achieve a rapid minimum effective concentration.
• Ex. Digoxin (digitalization)
II. Pharmacotherapeutics
• use of drugs to treat disease.
A. Types of Therapies:
1. acute therapy
• px is critically ill & requires immediate intensive therapy
2. empiric therapy
• based on practical experience rather than on pure scientific data
3. maintenance therapy
• chronic conditions that don’t resolve
5. supportive therapy
• doesn’t treat the cause of disease but maintains other threatened body systems
until the patient’s condition resolve.
6. palliative therapy
• used for end-stage or terminal diseases to make the patient as comfortable as
possible
Drug Effects:
Main effect
• desired therapeutic effect
• reason drug is administered
Side effects
• physiologic effects that are not related to desired drug effects
• expected, well-known reactions that result in little or no change in patient intervention
Adverse Reactions
• more severe than side effects
• undesirable & unexpected effects occurring even at normal dose
Placebo Effect
• a therapeutic effect that results from a patient’s belief in the benefits of a medication
Drug interactions
• occur bw drugs or bw drugs & foods
1. additive drug effect 2 drugs produce equivalent effects when either drug is given alone
in higher doses.
3. antagonistic – combined effects of 2 drugs are less than the effect produced by
the 2 individual drugs
b. Hypersensitivity or hypersusceptibility
• excessive therapeutic response even with usual therapeutic dose
ex. anticholinergics dry mouth, blurring of vision, urinary retention & constipation
narcotic analgesic
oral contraceptives
digitalis
aspirin
d. Iatrogenic effects
• adverse reactions that caused by drugs that are part of medical tx.
• drug-induced diseases
f. dependence
• strong physical & psychological
need for a certain drug
habituation
addiction
g. cumulation
• body cannot metabolize & excrete one dose of a drug completely before
the next dose.
Types:
1. Immediate allergic reaction :
Urticaria
sxs:
• skin rash with severe itching
• swelling
Anaphylaxis
sxs:
• dyspnea
• extreme weakness
• nausea & vomiting
• cyanosis
• hypotension
• circulatory collapse
b. Idiosyncratic reactions:
• unique or strange responses to certain drugs thought
to be caused by genetic factors
ex. succinylcholine
primaquine
a. Teratogenic
• produce organ defects in developing fetus
alcohol
aminoglycoside
b. Carcinogenic
• induce malignant changes in cells
c. Mutagenic
• produce genetic mutations
A. Dermatological reactions:
Sxs:
• hives/ urticaria
• rash
• exfoliative dermatitis
• Stevens- Johnson syndrome
Tx:
• frequent skin care
• notify prescriber & discontinue drug
• topical corticosteroids, antihistamine & emollients
B. Stomatitis
S/sxs:
• swollen gums & tongue.
• difficulty swallowing
• bad breath
• pain in mouth & throat
Tx:
• frequent mouth care
• frequent, small meals
D. Gingival hyperplasia
S/sxs:
• red, & enlarged gums
E. Superinfections
S/sxs:
• fever
• diarrhea
• hairy tongue
• mucous membrane lesions
• vaginal discharge
ex. antibiotics
F. Blood dyscrasias
agranulocytosis*
anemia
thrombocytopenia
s/sxs:
• fever & chills
• extreme weakness
• sore throat
• high risk to infection
• high risk for bleeding/hemorrhage
tx.
• monitor blood counts
• protect from exposure to infection
• avoid activities that result in injury or bleeding
G. Hepatotoxicity
s/sxs:
• jaundice*
• fever
• nausea & vomiting
• increase in liver enzymes (AST & ALT)
• altered bilirubin
H. Nephrotoxicity
s/sxs
• edema
• increase Crea & BUN
• decrease hematocrit
• electrolyte imbalances
I. Ototoxicity
s/sxs
• dzziness
• ringing in ears
• loss of balance
• hearing problem
J. Ocular toxicity
s/sxs
• burring of vision
• color vision changes
• blindness
K. Hypoglycemia
s/sxs
• headache
• tremors
• drowsiness
• cold clammy skin
• seizures/coma
M. Hypokalemia
s/sxs
• serum K
• irregular, weak pulse
• weakness & numbness of extremities
• paralytic ileus
o absent bowel sounds
o abdominal distention
S. Photosensitivity
s/sxs
• itching
• scaling
• reddening of skin
Ex. sulfonamides, tetracycline